Search - tctmd.com

Displaying 1 - 20 of 161

Sort: Relevancy | Date

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Presentation TCT India 2025

Hybrid PCI-Less Metal More Medicine

Presenter: Sanjeev Gera

July 26, 2025

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation JIM 2020

Retrograde Bail-Out Strategy for Iatrogenic Dissection of the Right Coronary Artery

Presenter: Emily Mae Yap

February 15, 2020

Presentation

Association of Sex With Outcomes in Patients Undergoing PCI

January 31, 2020

Presentation

Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD

November 14, 2019

Presentation

Identification of Patients at Higher Risk for Myocardial Injury Following Elective PCI

October 29, 2019

Presentation TCT Abstracts Posters 2019

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Presenter: Cecillia Y Wong

October 28, 2019

Presentation TCT Abstracts Posters 2019

The Role of In Silico Coronary Arterial Vessel Reconstruction in Determining the Accuracy of Virtual Diagnostic Workflows for Coronary Artery Disease

Presenter: Roshni Solanki

October 09, 2019

Presentation TCT Abstracts Posters 2019

A Meta-analysis of Percutaneous Coronary Intervention in Small Vessel Coronary Artery Disease using Drug-coated Balloon versus Drug-coated Stent

Presenter: Kifah Hussain

September 29, 2019

Presentation Fellows 2019

The Evolution in PCI Pharmacology Over the Past 25 Years

Presenter: Deepak L. Bhatt

April 12, 2019

Presentation OPCI 2019

When treating (severely) calcified CAD, rotational or orbital atherectomy is mandatory

Presenter: Emmanouil S. Brilakis

March 09, 2019

Presentation OPCI 2019

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes

Presenter: Habib Samady

March 09, 2019

Presentation OPCI 2019

High Definition IVUS as a tool to optimize PCI

Presenter: Akiko Maehara

March 09, 2019

Presentation OPCI 2019

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

Presenter: William F. Fearon

March 09, 2019

Presentation JIM 2019

GP IIb/IIIa inhibitors are still the best option

Presenter: Alberto Menozzi

February 15, 2019

Presentation

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

May 21, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

Advertisement

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Hybrid PCI-Less Metal More Medicine

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Retrograde Bail-Out Strategy for Iatrogenic Dissection of the Right Coronary Artery

Association of Sex With Outcomes in Patients Undergoing PCI

Dobutamine Stress Echo Ischemia a Predictor of PCI Efficacy in Stable CAD

Identification of Patients at Higher Risk for Myocardial Injury Following Elective PCI

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

The Role of In Silico Coronary Arterial Vessel Reconstruction in Determining the Accuracy of Virtual Diagnostic Workflows for Coronary Artery Disease

A Meta-analysis of Percutaneous Coronary Intervention in Small Vessel Coronary Artery Disease using Drug-coated Balloon versus Drug-coated Stent

The Evolution in PCI Pharmacology Over the Past 25 Years

When treating (severely) calcified CAD, rotational or orbital atherectomy is mandatory

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes

High Definition IVUS as a tool to optimize PCI

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

GP IIb/IIIa inhibitors are still the best option

Trends in P2Y12 Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After PCI, 2008-2016

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content